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Abstract
Background: Iron deficiency anaemia is a worldwide health problem in which environmental, physiologic and
genetic factors play important roles. The associations between iron status biomarkers and single nucleotide
polymorphisms (SNPs) known to be related to iron metabolism were studied in menstruating women.
Methods: A group of 270 Caucasian menstruating women, a population group at risk of iron deficiency anaemia,
participated in the study. Haematological and biochemical parameters were analysed and 10 selected SNPs were
genotyped by minisequencing assay. The associations between genetic and biochemical data were analysed by
Bayesian Model Averaging (BMA) test and decision trees. Dietary intake of a representative subgroup of these
volunteers (n = 141) was assessed, and the relationship between nutrients and iron biomarkers was also
determined by linear regression.
Results: Four variants, two in the transferrin gene (rs3811647, rs1799852) and two in the HFE gene (C282Y, H63D),
explain 35% of the genetic variation or heritability of serum transferrin in menstruating women. The minor allele of
rs3811647 was associated with higher serum transferrin levels and lower transferrin saturation, while the minor
alleles of rs1799852 and the C282Y and H63D mutations of HFE were associated with lower serum transferrin levels.
No association between nutrient intake and iron biomarkers was found.
Conclusions: In contrast to dietary intake, these four SNPs are strongly associated with serum transferrin. Carriers
of the minor allele of rs3811647 present a reduction in iron transport to tissues, which might indicate higher iron
deficiency anaemia risk, although the simultaneous presence of the minor allele of rs1799852 and HFE mutations
appear to have compensatory effects. Therefore, it is suggested that these genetic variants might potentially be
used as markers of iron deficiency anaemia risk.
Keywords: Transferrin gene, HFE gene, serum transferrin, transferrin saturation, iron deficiency anaemia, SNP, men-
struating women, iron intake, association study, genetic markers
Introduction
Iron deficiency is one of the leading risk factors for dis-
ability and mortality worldwide, affecting both develop-
ing and developed countries with major consequences
for human health as well as social and economic
improvement. An estimated two billion people are
affected, and menstruating women and children are
populations at risk [1].
Iron deficiency anaemia is caused by a wide variety of
factors that can be isolated, but more often coexist [2].
It results from any situation in which dietary iron intake
does not meet the body’s demands. Physiological blood
loss frequently contributes to the negative iron balance,
but genetic factors also play a role [3].
It is well established that in a situation of iron-defi-
ciency the supply of iron to transferrin is compromised,
increasing the serum levels of the protein while
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transferrin saturation and total iron binding capacity are
decreased; this leads to ferritin stores being progressively
diminished [2]. More recently, hepcidin has emerged as
the central regulatory molecule of systemic iron home-
ostasis, inhibiting ferroportin which mediates iron
export from hepatocytes, duodenal enterocytes and
macrophages. Hepcidin mRNA is transcriptionally regu-
lated through at least three pathways: interleukin 6 sti-
mulates hepcidin expression through the STAT3
signaling pathway; bone morphogenetic proteins (BMP)
increase hepcidin expression through the haemojuvelin/
BMP receptor/Smad 4 pathway; and transferrin stimu-
lates hepcidin expression through a transferrin receptor
2 (TfR2)/HFE mediated pathway [4].
Mutations of several genes implicated in iron-overload
have been widely studied. Haemochromatosis can be
caused by mutations affecting any of the proteins that
limit the entry of iron into the blood. In humans, muta-
tions in HFE, TfR2, haemojuvelin and ferroportin genes
can result in haemochromatosis [5].
However, limited information is available about gene
variants associated with iron deficiency anaemia [6].
Atransferrinemia, due to rare mutations in the transferrin
gene (TF), leads to low or undetectable levels of the carrier
protein [7]. Mutations in the divalent metal transporter 1
gene have been found in patients with microcytic anaemia,
low serum ferritin, and liver iron overload [8]. Recent stu-
dies revealed that mutations in the matriptase gene
(TMPRSS6) cause iron-refractory iron deficiency anaemia
[9]. Presence of the mutation G277S of the TF gene alone
does not affect iron absorption in iron deficient women
[10-12] and it has been suggested that a combination of
polymorphisms is involved in iron metabolism [13].
The development of genome-wide association studies
(GWAS) make it possible to associate genetic variations,
such as single nucleotides polymorphisms (SNPs), with
traits that could be related to a disease. Recent GWAS
studies are available on clinically relevant haematological
traits that determine iron status, such us haemoglobin
levels, mean corpuscular volume, serum ferritin, serum
transferrin and transferrin saturation [14-17]. Benyamin
et al. (2009) demonstrated that three variants in TF plus
the HFE C282Y mutation explain approximately 40% of
genetic variation in serum transferrin [18]. Remacha et
al. (2006) detected two quantitative trait loci that sug-
gest linkage to soluble transferrin receptor [19].
All of these studies provide insight into haematopoie-
tic pathways and reveal genetic variants that may predis-
pose some individuals to iron deficiency and related
disorders. The present study is part of a wider project
aimed at investigating the influence of dietary, physiolo-
gical, and genetic risk factors on iron deficiency anae-
mia. In this work, the associations between iron status
biomarkers and 10 SNPs known to be related with iron
metabolism were studied in menstruating women, a
population group at risk of iron deficiency anaemia.
Design and methods
Subjects
A group of 270 menstruating women participated in the
study. The inclusion criteria were: Caucasian, aged 18-
45 years, non-smoker, non-pregnant, non-breastfeeding.
Subjects were excluded from the study if they had ame-
norrhea, menopause, thalassaemia, haemochromatosis,
chronic gastric diseases (inflammatory bowel disease,
Crohn disease, gastric ulcers, celiac disease, haemorrha-
gic diseases) or renal disease.
The study protocols were approved by the Clinical
Research Ethics Committee of Hospital Puerta de
Hierro, Madrid and the Spanish National Research
Council (CSIC), Madrid, Spain.
Dietary control and anthropometric measures
The dietary intake and anthropometric measures of a
randomly selected subgroup of these volunteers were
assessed (n = 141). They completed a 72-h detailed diet-
ary intake report, previously validated and proved valu-
able to assess nutrient intake [20,21], specifying the
types of food consumed and serving weights. Daily food,
energy intake, nutrient intake and energy provided by
macronutrients were calculated by a computer applica-
tion using the Spanish Food Composition Database [22].
Anthropometric measures were taken using standar-
dised procedures. Body weight was measured with a
calibrated Seca scale (to a precision of 100 g) and height
was measured at baseline with a stadiometer incorpo-
rated into the scale. Body mass index (BMI) was calcu-
lated as weight/height squared (kg/m2).
Blood sampling and biochemical assays
Blood samples were collected by venipuncture after a
12-h fasting period, between 08:00 h and 09:00 h. Serum
and plasma were obtained after centrifugation at 1000 g
for 15 minutes and stored at -80°C.
Total red blood cells, haematocrit, mean corpuscular
volume (MCV) and haemoglobin were determined fol-
lowing standard laboratory techniques using the Symex
NE 9100 automated haematology analyser (Symex, Kobe,
Japan). Serum iron, serum ferritin and serum transferrin
were determined by the Modular Analytics Serum Work
Area analyser (Roche, Basel, Switzerland). Transferrin
saturation (%) was calculated as follows: serum iron
(μmol/L)/TIBC (μmol/L) × 100, where TIBC is total iron
binding capacity, calculated as 25.1 × transferrin (g/L).
SNP’s selection and genetic analysis
A total of 10 SNPs, known to be related to iron metabo-
lism, were selected from the bibliography. Six of them
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(rs3811647, rs1799852, rs2280673, rs1800562, rs4820268
and rs855791) were described in independent GWAS to
be related to iron biomarkers [14-18] and three more
(rs16826756, rs2673289 and rs1375515) were selected by
The HapMap Project (http://www.hapmap.org/) from
two linkage signals described by Remacha et al [19].
The last one (rs1799945) was chosen for its importance
in iron-related diseases [23].
A 10-multiplex minisequencing assay (SNaPshot) was
developed to genotype the 10 SNPs. Conditions of this
multiplex method were reported previously [24].
Statistics analysis
A normal distribution of the parameters was determined
by the Kolmogorov-Smirnov test. Serum ferritin values
were log transformed for statistical testing. Genotype
data quality was verified for each SNP by testing for
Hardy-Weinberg equilibrium using Chi-squared test.
Pearson’s correlation was used to study the associations
between quantitative variables.
Bayesian Model Averaging (BMA) was used to analyse
the associations between SNPs and variables (iron status
parameters), assuming a co-dominance model. BMA
accounts for the model uncertainty inherent in the vari-
able selection process by averaging over the best models
according to approximate posterior model probability.
BMA estimates all of the possible models and calculates
a probabilistic average of the effect of each SNP. The
significance threshold was a posterior effect probability
(P(b≠0|D)) ≥ 75%.
The proportion of the variance of one parameter
explained by one SNP is calculated as follows: [Var
(fenotype)-Var(e)]/Var(fenotype), where Var(fenotype) is
the variance of the parameter and Var(e) is the variance
of the residuals of the best model.
The relations between SNPs and variables were also
tested by a Chi-square automatic interaction detection
decision tree. Data are presented in a hierarchical way
according to the SNP that better explains the differences
in the studied variable. Each generated subdivision is
again divided according to the existence of new predic-
tors with a significant effect. The minimum size a node
could present to be divided to was 20 individuals and
the minimum size in a child node was 5 individuals, and
the significance threshold was p ≤ 0.01.
Chi-squared test was performed by GenePop software
(version 4.0). The Kolmogorov-Smirnov test, Pearson’s
correlation and decision tree were carried out by SPSS
statistical package for Windows (version 17.0) and the
BMA analysis was carried out using R statistic package.
Results
Age of the participating women was 24.3 ± 4.8 years
(mean ± SD) and body mass index (kg/m2) 21.7 ± 2.2.
There were no significant differences between iron sta-
tus biomarkers of the total group and the subgroup of
volunteers whose dietary intake was assessed (Table 1).
Dietary characteristics of the subgroup are presented on
Table 2. No significant associations between nutrient
intake and iron status parameters were found.
There were significant negative correlations between
serum transferrin and haemoglobin, haematocrit, MCV,
serum ferritin, and transferrin saturation (p < 0.001),
but the correlation between serum transferrin and
serum iron was not significant. All of the studied SNPs
were in Hardy-Weinberg equilibrium and presented a
minor allele frequency (MAF) higher than 0.01, there-
fore none of them were removed from the study.
Table 3 presents the results of the association analysis
between the 10 SNPs and serum transferrin, obtained by
BMA. It contains the posterior means (the mean effect
of the SNP across all the calculated models), standard
deviations and posterior effect probabilities (P(b≠0|D))
of the SNPs to be associated with serum transferrin, and
shows the models with the highest posterior probabil-
ities, from a total of 210 possible models. Four SNPs,
(rs3811647, rs1800562, rs1799945, rs1799852) were
included in the best model according to its posterior
model probability, 43.8%, which is much higher than
that of the second model (18.3%).
Table 1 Iron biomarkers of the total group and the
subgroup of volunteers
Total group
(n = 270)
Subgroup
(n = 141)
Haemoglobin (g/dl) 13.1 ± 0.9 13.2 ± 0.9
Haematocrit (%) 39.2 ± 2.7 39.2 ± 2.8
Mean Corpuscular Volume (fl.) 87.2 ± 5.0 86.9 ± 5.0
Serum Ferritin (ng/ml) 25.1 ± 21.3 25.5 ± 16.9
Serum Transferrin (mg/dl) 307.5 ± 54.1 311.5 ± 56.7
Serum iron (μg/dl) 81.7 ± 37.5 80.0 ± 36.
Transferrin saturation (%) 19.4 ± 10.2 18.8 ± 8.7
Differences between groups were not significant. Data are mean ± SD
Table 2 Energy and nutrient intake
Energy (kcal) 2125 ± 578
Protein (g) 83.3 ± 22.4
Carbohydrate (g) 215.7 ± 63.7
Lipid (g) 97.4 ± 30.4
Protein (% energy) 15.8 ± 6.6
Carbohydrate (%energy) 44.1 ± 7.2
Lipid (%energy) 40.3 ± 8.0
Dietary fiber (g) 19.2 ± 7.0
Calcium (mg) 937 ± 306
Iron (mg) 14.1 ± 4.2
Vitamin C (mg) 124.0 ± 58.5
Data are mean ± SD. n = 141 volunteers
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The SNPs rs3811647 and rs17999852, located in the
transferrin gene, yielded probabilities of 100% and 78%
respectively of being associated with serum transferrin.
Each A allele of the rs3811647 has an additive effect of
20.32 in the levels of serum transferrin while the T allele
of rs1799852 presents an reducing effect of 20.25. These
two SNPs explained 8.08% (rs3811647) and 5.55%
(rs1799852) of the total variation of serum transferrin.
The SNPs rs1800562 (C282Y) and rs1799945 (H63D),
located in the HFE gene, yielded probabilities of 100%
and 85.6% respectively of being associated with transfer-
rin levels. The A allele of rs1800562 accounts for a
mean reduction of 44.87 in the levels of transferrin,
which is the largest effect out of the four SNPs included
in the best model, whereas SNP rs1799945 presents a
negative mean effect of each G allele of 15.73. These
two SNPs explain 3.07% and 2.40% of the total variation
in transferrin respectively.
In the best model, the total phenotypic variation of
serum transferrin explained by these SNPs (rs3811647,
rs1799852, rs1800562 and rs1799945) is 16.9%.
There were no associations between SNPs rs4820268,
rs855791, rs2280673, rs2673289, rs137515, rs16826756
and levels of serum transferrin (Table 3). The associa-
tions between any of the SNPs and the other studied
iron biomarkers were not significant by BMA (models
not presented).
Figures 1 and 2 show the decision trees for serum
transferrin and transferrin saturation. With regard to
serum transferrin, rs3811647 is the SNP that better
explains this variable. Serum transferrin was significantly
higher in AA women (342.2 ± 67.3 mg/dL) than AG
heterozygous (314.6 ± 51.6 mg/dL) and GG homozygous
(292.2 ± 48.7 mg/dL) (p < 0.001). The GG node for SNP
rs3811647 is subdivided into two subgroups for the pre-
sence of rs1799852 (nodes 4 and 5). The CC genotype
for this SNP presented significantly higher values of
serum transferrin levels (301.4 ± 46.5 mg/dL) than the
CT genotype (276.4 ± 48.7 mg/dL). The homozygous
AA node for rs3811647 is subdivided into two other
subgroups for the presence of SNP rs1800562 (C282Y)
(nodes 6 and 7). The GG genotype for this SNP pre-
sented significantly higher values of serum transferrin
levels (361.4 ± 61.0 mg/dL) than the GA genotype
(265.4 ± 16.6 mg/dL). No subjects homozygous for T in
rs17999852 or for A in C282Y mutation were found.
Accordingly, rs3811647 was also found to be the SNP
that better explained transferrin saturation (Figure 2),
with significantly lower values in AA and AG women
(18.2 ± 8.7%) compared to GG homozygous women
(21.8 ± 10.9%) (p = 0.007).
Discussion
The present study shows that four SNPs, two in the TF
gene and two others in the HFE gene, explain a large
proportion of the genetic variation of serum transferrin
in a group of menstruating women. In the best model
calculated by BMA, the total phenotypic variation of
serum transferrin explained by these SNPs is 16.9%. The
estimated heritability of serum transferrin for Caucasian
woman, which is the proportion of phenotypic variation
in a population due to genetic variation, is 0.49 [25].
Therefore, these four SNPs can explain approximately
35% of the total genetic variation or heritability for
serum transferrin in this population group (calculated as
16.9/0.49).
Table 3 BMA association analysis between the 10 SNPs and serum transferrin
SNP P(b≠0|D) Mean b|D SD b|D Model 1 Model 2 Model 3 Model 4 Model 5
Intercept 100 304.746 6.724 307.878 300.740 301.542 305.256 303.681
rs4820268 4.6 0.205 1.318 4.475
rs855791 3.5 0.109 0.987
rs1799852 78 -15.896 10.747 -20.255 -21.078 -20.386 -20.314
rs2280673 2.8 0.039 0.812
rs1800562 100 -44.213 12.089 -44.875 -45.083 -40.336 -44.997 -44.276
rs3811647 100 21.223 5.224 20.322 24.300 20.720 20.267 20.042
rs2673289 4.4 0.190 1.278
rs1375515 2.8 0.037 0.810
rs1799945 85.6 -13.482 7.486 -15.737 -16.293 -15.044 -15.134
rs16826756 5.5 0.357 1.961 6.514
nVar 4 3 3 5 5
r2 0.169 0.146 0.142 0.173 0.172
BIC -27.431 -25.688 -24.606 -23.278 -22.919
Posterior model probability 0.438 0.183 0.107 0.055 0.046
P(b≠0|D): Probability of the SNP to be associated to the variable. Mean b|D: Posterior mean of the beta parameter (weighted average of the posterior means of
beta under each of the models). SD b|D: Standard deviation of each beta. Model1...5: Most probable multiple-SNP models. nVar: Number of SNPs included in the
model. BIC: Bayesian Information Criterion. r2: Coefficient of determination
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The dietary study showed that mean dietary iron intake
was below the Recommended Dietary Allowance for this
population group (18 mg/day) [26], which, as previously
reported by our research group [27,28], is not easily
reached in menstruating women. Although the influence
of dietary components on iron absorption is well known
[29], in the present study no association between nutrient
intake and iron biomarkers was found. This is outstand-
ing taking into account the wide range in iron biomarker
levels that these volunteers presented. Moreover, these
results are in agreement with other findings of our
research group obtained in a study that compared iron
status after consuming red meat or fish-based diets [27].
Serum transferrin and transferrin saturation are valid
parameters that reflect iron status in this group of men-
struating women as serum transferrin was inversely cor-
related with serum ferritin, haemoglobin, MCV,
haematocrit and transferrin saturation [2].
Regarding the SNPs in TF, the two statistical analyses
used led to coincident results, indicating that the
presence of the minor allele A in rs3811647 is related to
higher circulating transferrin levels whereas the minor
allele T in rs1799852 relates to lower levels. These
results from a sample of menstruating Caucasian
women are consistent with and replicate data obtained
by GWAS in other population groups [17,18,30].
SNP rs3811647 is situated in intron 11 and rs1799852
is a non-synonymous coding SNP in exon 17 of TF. As
these TF variants are associated with serum transferrin
concentration, they would appear to be involved at a
transcriptional or postranscriptional level [31]. In this
sense, further studies should be done in order to study
the influence that these two SNPs could have on the
action of these transcription factors and on transferrin
expression.
Present results also show that rs3811647 is associated
with transferrin saturation, in agreement with the asso-
ciation observed with serum transferrin and with find-
ings obtained in other populations [18]. Considering
that transferrin saturation is a marker of the iron supply
Figure 1 Decision tree built with serum transferrin as dependent variable and the 10 SNPs as independent variables or factors. %:
Percentage of the total sample included in each node.
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to tissues, A carriers present a reduction in iron trans-
port to tissues, as occurs in iron deficiency anaemia.
Another study found that SNP rs3811647 was also asso-
ciated with ferritin, although to a lesser degree than
with transferrin and transferrin saturation [18]. In the
present study, however, an association between this SNP
and serum ferritin was not observed, which can be
explained as ferritin is the final marker of iron stores,
indirectly related to iron transport, and also due to the
sample size.
The other two SNPs included in the best model for
the BMA test, rs1800562 and rs1799945 (C282Y and
H63D mutation respectively), are in HFE. The minor
allele of C282Y was associated with lower levels of
serum transferrin, which is consistent with other studies
[17,18,30]. Moreover, the present study shows that
H63D was also associated with serum transferrin. Both
SNPs are well known to be related to type I haemochro-
matosis [5], however the information concerning their
roles in iron deficiency is very scarce. High iron status
was observed in heterozygotes women, for either C282Y
or H63D, compared with women lacking these muta-
tions [32-34]. The present results confirm previous
observations of our group [13] and support the hypoth-
esis that C282Y and H63D mutations could have a pro-
tective effect against the development of anaemia in
menstruating women. In this line, studies suggest that
the haemochromatosis gene may have spread because of
a selective advantage through protection of heterozy-
gotes against iron deficiency [33,35].
Figure 2 Decision tree built with transferrin saturation as dependent variable and the 10 SNPs as independent variables or factors. %:
Percentage of the total sample included in each node.
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The study of interactions of these variants shows that
the presence of G in rs3811647 and T in rs1799852 has
a cumulative effect, with carriers of these variants pre-
senting lower serum transferrin levels (Figure 1). In the
presence of the minor allele A in rs3811647, that has
been clearly associated with higher transferrin levels, the
simultaneous presence of A in C282Y has a compensat-
ing favourable effect.
These four SNPs in TF and HFE may play a role in
iron regulation because, as suggested in a recent study,
the Tf/TfR2/HFE complex is critical for hepcidin regula-
tion, and the concentration of diferric serum transferrin
may act as a positive regulator, increasing hepcidin
expression [36]. Mutations in either TfR2 or HFE can
result in iron overload, which is characterised by low
hepcidin expression [37]. However, there is no informa-
tion concerning the possible compensatory effect on
iron overload of the minor allele A of rs3811647. As
these SNPs are found in genes for interrelated proteins
that participate in one of the iron-metabolism pathways,
it is suggested that the determination of these SNPs
may be useful and may have clinical repercussions either
in cases of iron deficiency or iron overload.
This work was focused on menstruating women
because they present a high iron deficiency anaemia
risk. According to WHO criteria [2], in this group of
menstruating women, 10.6% were anaemic, 45.8% iron
deficient and 43.7% iron sufficient women. This study
replicates the associations between SNPs and serum
transferrin and transferrin saturation observed pre-
viously in general population [17,18,30] and in HFE
mutation carriers [38], which is remarkable, considering
the size of this selected sample of menstruating women.
In addition, a new finding concerning the association
between H63D and serum transferrin, and the effects of
the interactions between SNPs are presented.
It is well known that environmental factors, such as
menstrual losses and nutrition, play an important role in
the development of iron deficiency anaemia. Regarding
menstruation, McLaren et al recently published a
genetic association study excluding menstruating
women in order to eliminate this possible confounding
factor [30]. However, our results are in agreement with
the association between rs3811647 and TIBC found by
those authors, and in addition, an association between
this SNP and transferrin saturation was found.
These data suggest that, even though there are envir-
onmental and physiological factors involved in the
development of iron deficiency anaemia, there are other
factors, such as genetics, that could predispose to the
disease. This may influence the choice of strategies for
the prevention of iron deficiency anaemia in the popula-
tion. In this regard, our group carried out a placebo-
controlled nutritional intervention with an iron fortified
food in iron deficient women. The iron-fortified food
markedly increased iron status, except in women that
presented the minor allele of SNP rs3811647 [39]. These
results may add new information to the area of nutrige-
netics and nutrigenomics, since research on iron meta-
bolism and gene-diet interaction is scarce.
To sum up, a large percentage of genetic variation of
serum transferrin was explained by two SNPs located in
the TF gene (rs3811647, rs1799852) and two in the HFE
gene (C282Y, H63D) in menstruating women. In contrast
to dietary intake, these SNPs are strongly associated with
serum transferrin, and A carriers of rs3811647 present a
reduction in iron transport to tissues, which might indi-
cate higher iron deficiency anaemia risk. Moreover, the
study of interactions of these variants shows that presence
of the different alleles could have a cumulative or compen-
sable effect in serum transferrin levels. Therefore, it is sug-
gested that these genetic variants might potentially be
used as markers of iron deficiency anaemia risk.
Further investigations in anaemic and non-anaemic
subjects should be designed to increase the existing
knowledge of the relationship between genetic variants
and iron deficiency anaemia, and the possible modulat-
ing effect of diet and menstruation. Present results may
be also useful to increase knowledge on iron overload
disorders. It is also important to study the possible
gene-diet interaction effects on the recovery of iron sta-
tus. Finally, other studies should be carried out to
explore the mechanisms by which these variants, or
combination of variants as in haplotypes, affect iron
metabolism at the transcriptional and postranscriptional
levels and also at the functional level.
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